Mesa Laboratories, Inc. (NasdaqGS: MLAB)
Health Care · Life Sciences Tools & Services · US
$130.30
+2.32% today · +76.7% 1Y
Mesa Laboratories, Inc. (NasdaqGS: MLAB) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $712.63M and employs 717 people.
Over the last twelve months the share price has gained 76.7%, trading between 58.83 and 120.45.
Tweenvest scores Mesa Laboratories, Inc. across four factors: quality 69/100, value 53/100, growth 63/100, dividend 27/100. Its strongest factor is quality.
MLAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $712.63M
- Revenue (TTM)
- $249.72M
- P/E
- 147.94
- EPS
- 0.86
- Dividend yield
- 0.51%
- Beta (5Y)
- 0.93
- 52-week high
- $120.45
- 52-week low
- $58.83
- Avg volume (3M)
- —
- Shares outstanding
- 5.60M
- Employees
- 717
- Next earnings
- —
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
- ISIN
- US59064R1095
- Founded
- 1982
- Listed since
- Feb 29, 1984
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.99 | +0.01% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF592.80 | -0.17% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $155.20 | +0.28% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $261.00 | +0.61% |
| Waters CorporationNYSE: WAT | $40.72B | $418.99 | +1.10% |
Figures last refreshed Aug 18, 2026.